-
281
Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice
Published 2022-03-01Subjects: Get full text
Article -
282
Response rates to a mailed survey of a representative sample of cancer patients randomly drawn from the Pennsylvania Cancer Registry: a randomized trial of incentive and length effects
Published 2010-07-01“…</p> <p>Methods</p> <p>In a pilot study, 1200 breast, prostate and colon patients, randomly selected from the Pennsylvania Cancer Registry, were sent surveys in the mail. Incentive amount ($3 vs. $5) and length of the survey (10 pages vs. 16 pages) were randomly assigned.…”
Get full text
Article -
283
-
284
-
285
Renal Cell Carcinoma Health Disparities in Stage and Mortality among American Indians/Alaska Natives and Hispanic Americans: Comparison of National Cancer Database and Arizona Cancer Registry Data
Published 2021-02-01“…RCC patients’ data were obtained from the National Cancer Database (NCDB) and Arizona Cancer Registry (ACR). Logistic and Cox regression analyses were performed to ascertain the effect of race/ethnicity on stage and mortality, adjusting for neighborhood socioeconomic factors, rural/urban residence pattern, and other factors. …”
Get full text
Article -
286
BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010–2013: An observational study using state cancer registry and All‐Payer claims data
Published 2022-07-01“…Methods We identified breast cancer diagnoses in the Massachusetts Cancer Registry from 2010 to 2013 and linked registry data with Massachusetts All‐Payer Claims Data from 2010 to 2014 among women aged ≤45 years with private insurance or Medicaid. …”
Get full text
Article -
287
-
288
Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO).
Published 2022-01-01“…<h4>Methods</h4>We conducted a multi-center cohort study, using hospital-based cancer registry (HBCR) data linked to administrative data from 66 designated cancer care hospitals in Osaka. …”
Get full text
Article -
289
Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000–2015
Published 2023-04-01Subjects: Get full text
Article -
290
Second Primary Cancers in a Population-Based Mesothelioma Registry
Published 2023-03-01Subjects: Get full text
Article -
291
The incidence and trends of laryngeal malignancies in Sri Lanka from 2001 to 2019: a Joinpoint analysis of the national cancer database
Published 2023-02-01Subjects: Get full text
Article -
292
Projecting cancer prevalence by phase of care: a methodological approach for health service planning
Published 2023-08-01Subjects: Get full text
Article -
293
Survival of Patients with Sinonasal Cancers in a Population-Based Registry, Lombardy, Italy, 2008–2023
Published 2024-02-01Subjects: Get full text
Article -
294
Temporal trends in age- and stage-specific incidence of colorectal adenocarcinomas in Germany
Published 2023-12-01Subjects: Get full text
Article -
295
An Ontology to Model the International Rules for Multiple Primary Malignant Tumours in Cancer Registration
Published 2021-08-01Subjects: “…cancer registry…”
Get full text
Article -
296
Breast cancer and occupation: Non-parametric and parametric net survival analyses among Swiss women (1990–2014)
Published 2023-04-01Subjects: Get full text
Article -
297
-
298
Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data
Published 2022-06-01Subjects: Get full text
Article -
299
Age-Standardized Breast Cancer Detection Rates of Breast Cancer Screening Program by Age Group in Korea; Comparison with Age-Standardized Incidence Rates from the Korea Central Cancer Registry
Published 2020-05-01“…To compare the epidemiological characteristics of a breast cancer screening program of patients between 40–69 years of age and ≥70 years of age, we calculated the age-standardized detection rate of the breast cancer screening program and compared it with the age-standardized incidence rate from the Korea Central Cancer Registry. The data of the breast cancer screening program from January 2009 to December 2016 and the data of the health insurance claims from January 2006 to August 2017 were used. …”
Get full text
Article -
300
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
Published 2023-04-01“…This study investigated differences in incidence and time to diagnosis of brain metastasis and survival outcomes dependent on the type of first-line therapy.Methods Patients with metastatic, non-resectable melanoma (AJCCv8 stage IIIC–V) without brain metastasis at start of first-line therapy (1L-therapy) were identified from the prospective multicenter real-world skin cancer registry ADOREG. Study endpoints were incidence of brain metastasis, brain metastasis-free survival (BMFS), progression-free survival (PFS), and overall survival (OS).Results Of 1704 patients, 916 were BRAF wild-type (BRAFwt) and 788 were BRAF V600 mutant (BRAFmut). …”
Get full text
Article